P4‐206: Co‐treatment with Memantine and Compound 21, an Angiotensin II Type 2 Receptor Agonist, Prevents Cognitive Decline in Type 2 Diabetic Mice

Masaki Mogi,Jun Iwanami,Fei Jing,Kana Tsukuda,Masatsugu Horiuchi

DOI: https://doi.org/10.1016/j.jalz.2012.05.1911

2012-01-01

Abstract:Clinical studies reported that Type 2 diabetes mellitus (T2DM) is associated with increased risk of cognitive impairment and dementia including Alzheimer's disease (AD). We previously reported that T2DM model mice, KKAy, exhibit cognitive impairment compared with wild-type mice. However, therapeutical approach for T2DM-induced cognitive decline has not been well investigated. Central role of renin-angiotensin system (RAS) has been highlighted. RAS is considered to function with various neurotransmitters for learning and memory. Recently, interaction between angiotensin receptors and N-Methyl-D-aspartic acid (NMDA) glutamate receptors has been reported. We previously reported that angiotensin II type 2 (AT 2) receptor affects cognitive function and a direct AT 2 receptor agonist, compound 21 (C21), enhances cognitive function in wild-type mice. Here, we investigated the possibility of the therapeutic approach with memantine and C21 on T2DM-induced cognitive impairment. Ten week-old male KKAy mice were separated into four groups; 1) control, 2) 10 m g/kg/day C21 treatment 3) 20 mg/kg/day memantine treatment 4) treatment with both memantine and C21. Memantine and C21 were administrated by oral and intraperitoneal injection, respectively. Mice were subjected to the Morris water maze task for 5 days. Cerebral blood flow (CBF) was analyzed by laser speckle flowmetry after the cognitive task. Phosphorylation of NMDA receptors was accessed by immunoblot. Blood pressure and body weight were not different among all groups. In the Morris water maze, escape latency was shortened in C21 treatment group compared with control group. Interestingly, co-treatment with memantine significantly further shortened swim latency in C21-treated KKAy. CBF was increased in C21-treated group compared with control group. We investigated the effect of C21 on NMDA phosphorylation after water maze, and observed that treatment with C21 enhanced NMDA phosphorylation in the hippocampus. These results suggest that direct AT 2 receptor stimulation has a protective effect on cognitive decline in the Morris water maze in T2DM mice. Co-administration of memantine enhanced a C21-induced preventive effect, indicating that RAS is involved in memory and learning system by the interaction with neurotransmitter for NMDA receptor. Therefore, regulation of RAS may be a new strategy for diabetes-induced cognitive decline including AD.